Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
Subfraction 2R of fraction 9 from a peptic-tryptic-pancreatic digest of wheat gliadin is known to be toxic in vivo to celiac patients. We have found that fractions 9 and 2R inhibit the in vitro development of fetal rat intestine and the increase of enterocyte height occurring in organ culture of atrophic celiac mucosa (0.1-0.5 mg/ml medium). Other peptide fractions of the gliadin digest are devoid of such in vitro effects. Subfraction 2R, after incubation with morphologically normal small intestinal mucosa of celiacs in remission and ultrafiltration, was still very active in both culture systems at low concentration (0.1 mg/ml); on the contrary, subfraction 2R was inactivated after incubation with normal mucosa. These results are compatible with the hypothesis that there is a mucosal defect in handling gliadin peptides in celiac disease, and suggest that there is either a primary (or secondary) enzyme deficiency or some other mechanism operating in the intestinal mucosa of celiac patients in remission.
Cornell
H J
HJ
Department of Applied Chemistry, Royal Melbourne Institute of Technology, Melbourne, Australia.
Auricchio
R S
RS
De Ritis
G
G
De Vincenzi
M
M
Maiuri
L
L
Raia
V
V
Silano
V
V
D000818:Animals; D001284:Atrophy; D002446:Celiac Disease / Q000473:pathology*; D005333:Fetus; D005903:Gliadin / Q000494:pharmacology*; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D007421:Intestine, Small / Q000187:drug effects* / Q000473:pathology; D007583:Jejunum / Q000187:drug effects* / Q000473:pathology; D009924:Organ Culture Techniques; D010940:Plant Proteins / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D010940:Plant Proteins; D005903:Gliadin